Dermatology practical & conceptual · 2025
Distant Metastasis of Merkel Cell Carcinoma: A Descriptive Study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Muntaner-Virgili Clara, Boronat-Cucarull Júlia, Ferreres Josep Ramon, Gamissans Marta, Marcoval Joaquim, Fernández-Calvo Davinia, Penín Rosa María, Bermejo Josep, Huesa-Barceló Lia, Manzano-Mora Sergio, Ruzafa-Martínez Eric, Bajen-Lázaro María Teresa, Benítez-Segura Ana, Notta Paula Cecilia, Jiménez-Colomo Laura, Martín-Liberal Juan, Araguas-Mora Pablo, Juárez-Lozano Marc, Linares-Galiana Isabel
Аннотация
INTRODUCTION: There are few studies on the pattern of distant spread of Merkel cell carcinoma (MCC).
OBJECTIVES: To analyse the most frequent locations of distant metastases from MCC and their possible relationship with the location of the primary tumour.
METHODS: Patients diagnosed with cutaneous MCC between 1988 and 2022 were included in the study. The locations of the first metastases detected were recorded, both at tumour diagnosis and during follow-up after initial treatment.
RESULTS: One hundred patients were diagnosed with MCC. Distant metastases were detected in 31 patients (seven at diagnosis and 24 during follow-up), with a total of 52 locations: 17 non-regional lymph node metastases, 10 bone, seven liver, six lung, four non-regional cutaneous/subcutaneous, three pancreatic, two adrenal, two pharyngeal, and one mammary. No patient developed metastasis to the central nervous system. Recurrences occurred in 84% of patients before two years of follow-up. Although differences were not significant, MCCs located in the extremities tended to metastasize to extra-regional lymph nodes and those in the head and neck to bone, liver, and lung.
CONCLUSIONS: MCC produces metastases mainly in non-regional lymph nodes, bone, liver, and lung. Given its high frequency (1/3 of patients), we consider performing scheduled imaging tests during the first two years of follow-up advisable. Specific imaging tests for central nervous system could be reserved for patients with neurological symptoms.
OBJECTIVES: To analyse the most frequent locations of distant metastases from MCC and their possible relationship with the location of the primary tumour.
METHODS: Patients diagnosed with cutaneous MCC between 1988 and 2022 were included in the study. The locations of the first metastases detected were recorded, both at tumour diagnosis and during follow-up after initial treatment.
RESULTS: One hundred patients were diagnosed with MCC. Distant metastases were detected in 31 patients (seven at diagnosis and 24 during follow-up), with a total of 52 locations: 17 non-regional lymph node metastases, 10 bone, seven liver, six lung, four non-regional cutaneous/subcutaneous, three pancreatic, two adrenal, two pharyngeal, and one mammary. No patient developed metastasis to the central nervous system. Recurrences occurred in 84% of patients before two years of follow-up. Although differences were not significant, MCCs located in the extremities tended to metastasize to extra-regional lymph nodes and those in the head and neck to bone, liver, and lung.
CONCLUSIONS: MCC produces metastases mainly in non-regional lymph nodes, bone, liver, and lung. Given its high frequency (1/3 of patients), we consider performing scheduled imaging tests during the first two years of follow-up advisable. Specific imaging tests for central nervous system could be reserved for patients with neurological symptoms.